Shire files suit to protect Adderall patent

03/21/2007 | Forbes

U.K. drugmaker Shire PLC filed suit against Colony Pharmaceuticals, Actavis and an Actavis subsidiary, claiming infringement on Shire's patent for the attention deficit hyperactivity disorder drug Adderall. According to Shire, Colony announced in November 2004 that it would produce a generic version before the patent expired. The lawsuit was filed when Colony filed an abbreviated new drug application for a generic version.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Santa Clara, CA
Food & Drug Associate
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA